{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Conotoxines : Questions médicales les plus fréquentes",
"headline": "Conotoxines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Conotoxines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-20",
"dateModified": "2025-02-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Conotoxines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Venins de mollusque",
"url": "https://questionsmedicales.fr/mesh/D008978",
"about": {
"@type": "MedicalCondition",
"name": "Venins de mollusque",
"code": {
"@type": "MedicalCode",
"code": "D008978",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.946.833.590"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Conotoxines-oméga",
"alternateName": "omega-Conotoxins",
"url": "https://questionsmedicales.fr/mesh/D020960",
"about": {
"@type": "MedicalCondition",
"name": "Conotoxines-oméga",
"code": {
"@type": "MedicalCode",
"code": "D020960",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.946.833.590.162.720"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Conotoxine-oméga-GVIA",
"alternateName": "omega-Conotoxin GVIA",
"url": "https://questionsmedicales.fr/mesh/D020866",
"about": {
"@type": "MedicalCondition",
"name": "Conotoxine-oméga-GVIA",
"code": {
"@type": "MedicalCode",
"code": "D020866",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.946.833.590.162.720.700"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Conotoxines",
"alternateName": "Conotoxins",
"code": {
"@type": "MedicalCode",
"code": "D020916",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sulan Luo",
"url": "https://questionsmedicales.fr/author/Sulan%20Luo",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Tropical Biological Resources of Ministry of Education, Key Lab for Marine Drugs of Haikou, School of Life and Pharmaceutical Sciences, Hainan University, Haikou, Hainan, China."
}
},
{
"@type": "Person",
"name": "Dongting Zhangsun",
"url": "https://questionsmedicales.fr/author/Dongting%20Zhangsun",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Tropical Biological Resources of Ministry of Education, Key Lab for Marine Drugs of Haikou, School of Life and Pharmaceutical Sciences, Hainan University, Haikou, Hainan, China."
}
},
{
"@type": "Person",
"name": "Richard J Lewis",
"url": "https://questionsmedicales.fr/author/Richard%20J%20Lewis",
"affiliation": {
"@type": "Organization",
"name": "Institute for Molecular Bioscience , The University of Queensland , Brisbane Queensland 4072 , Australia."
}
},
{
"@type": "Person",
"name": "Xiaopeng Zhu",
"url": "https://questionsmedicales.fr/author/Xiaopeng%20Zhu",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Tropical Biological Resources of Ministry of Education, Key Laboratory for Marine Drugs of Haikou, School of Life and Pharmaceutical Sciences, Hainan University, Haikou 570228, China."
}
},
{
"@type": "Person",
"name": "David J Adams",
"url": "https://questionsmedicales.fr/author/David%20J%20Adams",
"affiliation": {
"@type": "Organization",
"name": "Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, Australia (A.R.B., J.R.M., D.J.A.); School of Science, RMIT University, Melbourne, Australia (A.K., A.H.); and School of Health and Biomedical Sciences, RMIT University, Bundoora, Australia (A.R.W) djadams@uow.edu.au andrew.hung@rmit.edu.au."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Emerging effects of non-coding RNA in vascular endothelial cells during strokes.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37059212",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.vph.2023.107169"
}
},
{
"@type": "ScholarlyArticle",
"name": "Single-cell RNA sequencing of intestinal immune cells in neonatal necrotizing enterocolitis.",
"datePublished": "2023-04-11",
"url": "https://questionsmedicales.fr/article/37041419",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00383-023-05461-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of alcohol and PARP inhibition on RNA ribosomal engagement in cortical excitatory neurons.",
"datePublished": "2023-04-11",
"url": "https://questionsmedicales.fr/article/37113267",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnmol.2023.1125160"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of cold-inducible RNA-binding protein (CIRBP) in response to cellular stresses.",
"datePublished": "2023-04-08",
"url": "https://questionsmedicales.fr/article/37037339",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biochi.2023.04.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cryoelectron microscopic structure of the nucleoprotein-RNA complex of the European filovirus, Lloviu virus.",
"datePublished": "2023-04-06",
"url": "https://questionsmedicales.fr/article/37124400",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/pnasnexus/pgad120"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Toxines biologiques",
"item": "https://questionsmedicales.fr/mesh/D014118"
},
{
"@type": "ListItem",
"position": 4,
"name": "Venins",
"item": "https://questionsmedicales.fr/mesh/D014688"
},
{
"@type": "ListItem",
"position": 5,
"name": "Venins de mollusque",
"item": "https://questionsmedicales.fr/mesh/D008978"
},
{
"@type": "ListItem",
"position": 6,
"name": "Conotoxines",
"item": "https://questionsmedicales.fr/mesh/D020916"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Conotoxines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Conotoxines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Conotoxines",
"description": "Comment diagnostiquer une intoxication par conotoxines ?\nQuels tests sont utilisés pour détecter les conotoxines ?\nQuels symptômes indiquent une intoxication par conotoxines ?\nLes conotoxines sont-elles détectables dans le sang ?\nY a-t-il des marqueurs biologiques pour les conotoxines ?",
"url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=RNA,+Long+Noncoding&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Conotoxines",
"description": "Quels sont les symptômes courants des conotoxines ?\nLes conotoxines provoquent-elles des troubles respiratoires ?\nPeut-on ressentir des douleurs après exposition aux conotoxines ?\nLes symptômes des conotoxines sont-ils immédiats ?\nY a-t-il des symptômes neurologiques associés aux conotoxines ?",
"url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=RNA,+Long+Noncoding&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Conotoxines",
"description": "Comment prévenir l'exposition aux conotoxines ?\nY a-t-il des mesures de sécurité pour les plongeurs ?\nLes conotoxines peuvent-elles être évitées par la cuisson ?\nLes enfants sont-ils plus à risque d'exposition ?\nDes campagnes de sensibilisation existent-elles ?",
"url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=RNA,+Long+Noncoding&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Conotoxines",
"description": "Quel est le traitement principal pour l'intoxication par conotoxines ?\nDes antidotes existent-ils pour les conotoxines ?\nComment gérer la douleur causée par les conotoxines ?\nLes soins intensifs sont-ils nécessaires pour les cas graves ?\nPeut-on utiliser des médicaments pour traiter les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=RNA,+Long+Noncoding&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Conotoxines",
"description": "Quelles complications peuvent survenir après une intoxication ?\nLes complications sont-elles réversibles ?\nY a-t-il un risque de décès lié aux conotoxines ?\nLes complications nécessitent-elles un suivi médical ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=RNA,+Long+Noncoding&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Conotoxines",
"description": "Qui est le plus à risque d'intoxication par conotoxines ?\nLes personnes allergiques sont-elles plus vulnérables ?\nL'âge influence-t-il le risque d'intoxication ?\nLes personnes avec des antécédents médicaux sont-elles plus à risque ?\nLes régions géographiques influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=RNA,+Long+Noncoding&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication par conotoxines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et les symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les conotoxines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biologiques et des analyses de sang peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication par conotoxines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent paralysie, douleur intense et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les conotoxines sont-elles détectables dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des méthodes spécifiques peuvent détecter les conotoxines dans le sang."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour les conotoxines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de marqueurs spécifiques pour les conotoxines."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des conotoxines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs, des nausées, et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les conotoxines provoquent-elles des troubles respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des difficultés respiratoires graves."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des douleurs après exposition aux conotoxines ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs aiguës et localisées sont fréquentes après exposition."
}
},
{
"@type": "Question",
"name": "Les symptômes des conotoxines sont-ils immédiats ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître rapidement, souvent en quelques minutes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés aux conotoxines ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la paralysie et des troubles de la coordination peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux conotoxines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de manipuler les cônes marins et portez des gants lors de la pêche."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures de sécurité pour les plongeurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les plongeurs doivent être formés aux risques liés aux cônes marins."
}
},
{
"@type": "Question",
"name": "Les conotoxines peuvent-elles être évitées par la cuisson ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La cuisson ne neutralise pas les conotoxines, il faut éviter leur consommation."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque d'exposition ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables en raison de leur curiosité."
}
},
{
"@type": "Question",
"name": "Des campagnes de sensibilisation existent-elles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des campagnes sensibilisent le public aux dangers des cônes marins."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'intoxication par conotoxines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique et peut inclure des soins de soutien en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les conotoxines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antidote spécifique pour les conotoxines."
}
},
{
"@type": "Question",
"name": "Comment gérer la douleur causée par les conotoxines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et des traitements symptomatiques sont utilisés pour gérer la douleur."
}
},
{
"@type": "Question",
"name": "Les soins intensifs sont-ils nécessaires pour les cas graves ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les cas graves peuvent nécessiter des soins intensifs pour surveiller la respiration."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des médicaments pour traiter les symptômes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent être administrés pour traiter les symptômes spécifiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une intoxication ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques et respiratoires peuvent survenir après l'exposition."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de décès lié aux conotoxines ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une intoxication sévère peut entraîner un risque de décès par paralysie respiratoire."
}
},
{
"@type": "Question",
"name": "Les complications nécessitent-elles un suivi médical ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical est souvent nécessaire pour évaluer les complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent avoir un impact significatif sur la qualité de vie."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'intoxication par conotoxines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les plongeurs, pêcheurs et personnes manipulant des cônes marins sont à risque."
}
},
{
"@type": "Question",
"name": "Les personnes allergiques sont-elles plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes allergiques peuvent avoir des réactions plus sévères aux conotoxines."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'intoxication ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les personnes avec des antécédents médicaux sont-elles plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des antécédents neurologiques peuvent être plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les régions géographiques influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque est plus élevé dans les régions côtières où vivent les cônes marins."
}
}
]
}
]
}
Vascular and neurological damage are the typical outcomes of ischemic strokes. Vascular endothelial cells (VECs), a substantial component of the blood-brain barrier (BBB), are necessary for normal cer...
Necrotizing enterocolitis (NEC) causes fatal intestinal necrosis in neonates, but its etiology is unknown. We analyzed the intestinal immune response to NEC....
Using single-cell RNA sequencing (scRNA-seq), we analyzed the gene expression profiles of intestinal immune cells from four neonates with intestinal perforation (two with NEC and two without NEC). Tar...
In all four cases, major immune cells, such as T cells (15.1-47.7%), B cells (3.1-19.0%), monocytes (16.5-31.2%), macrophages (1.6-17.4%), dendritic cells (2.4-12.2%), and natural killer cells (7.5-12...
Intestinal immunity in NEC subjects exhibited stronger inflammatory responses compared to non-NEC subjects. Further scRNA-seq and cellular analysis may improve our understanding of the pathogenesis of...
We report on the effects of ethanol (EtOH) and Poly (ADP-ribose) polymerase (PARP) inhibition on RNA ribosomal engagement, as a proxy for protein translation, in prefrontal cortical (PFC) pyramidal ne...
Cold-inducible RNA-Binding Protein (CIRBP) is a general stress-response factor in vertebrates harboring two domains: an RNA-recognition motif and a regulatory domain rich in RG/RGG motifs. CIRBP has b...
Lloviu virus (LLOV) is a novel filovirus detected in Schreiber's bats in Europe. The isolation of the infectious LLOV from bats has raised public health concerns. However, the virological and molecula...
Aplastic anemia (AA) is a bone marrow hematopoietic failure syndrome mediated by immune cells. The mechanism of this immune disorder is not well understood and therapeutic strategies still need to be ...
Studies have found that abnormalities in metabolisms promote the survival of AA cells. In recent years, an increasing number of studies have reported the immunosuppressive therapy for the treatment of...
The key genes involved in abnormal metabolic processes were Neustein neurotrophic factor (...
Molecule interaction analysis showed that tumor necrosis factor superfamily, member 12 (TNFSM12) in tumor necrosis factor (TNF) signaling was broadly activated in AA. In conclusion, we suppose that th...
Parkinson's disease (PD) can dramatically change cortical neurophysiology. The molecular basis for PD-related cortical changes is unclear because gene expression data are usually derived from postmort...
While primary bone malignancies make up just 0.2% of all cancers, osteosarcoma (OS) is the third most common cancer in adolescents. Due to its highly complex and heterogeneous tumor microenvironment (...
Deamination of adenine or cytosine in RNA, called RNA editing, is a constitutively active and common modification. The primary role of RNA editing is tagging RNA right after its synthesis so that the ...
Single-cell RNA sequencing (RNA-seq) has been demonstrated to be a proven method for quantifying gene-expression heterogeneity and providing insight into the transcriptome at the single-cell level. Wh...